Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

It appears Gerald wants to end the negative speculation.

Gerald Commissiong ?@G_Commish 2h

Dr. Saarma recent Cell publication is excellent, and confirms Dr. Urano's original work. Reproducibility is the hallmark of good science.


Gerald Commissiong ?@G_Commish 2h

Unfortunately for our detractors, science doesn't care about the share price. We are very excited about our current position and our future.


Gerald Commissiong ?@G_Commish 3h

Amarantus owns comp. of matter patents for MANF and certain use patent apps. We have also licensed certain use apps for MANF and CDNF.


Gerald Commissiong ?@G_Commish 3h

Dr. Saarma is excellent scientist. We have great appreciation for his work. MANF field emerging in cell biology. Dr. Saarma is a KOL on MANF


Gerald Commissiong ?@G_Commish 3h

Dr. Saarma challenged validity of broad scope of AMBS MANF patents in Europe in 2012. European Commission sided 100% with Amarantus. Period.


Gerald Commissiong ?@G_Commish 3h

MANF is not MANF2. Dr. Saarma discovered MANF2 after Dr. Commissiong discovered MANF. Dr. Saarma changed name of MANF2 to CDNF. MANF2 = CDNF


Gerald Commissiong ?@G_Commish 3h

Dr. Urano's application precedes Dr. Saarma's, and will represent prior art. Amarantus controls MANF indication in beta cell disorders.


Gerald Commissiong ?@G_Commish 3h

Amarantus is now paying for prosecution per our agreement with UMass and we will enter the nationalisation phase shortly.


Gerald Commissiong ?@G_Commish 3h

These patents have already published (1.5 year provisional, 1 year PCT) and Amarantus licensed them in December 2013.


Gerald Commissiong ?@G_Commish 3h

For clarity, there is no ambiguity: @FumihikoUrano conceived, reduced to practice, and filed patents for MANF beta cell indications in 2012


Retweeted by Gerald Commissiong
Zoomboom ?@zoneblitzzzz Apr 11

@biostockwatcher @JNapodano @G_Commish @FumihikoUrano Dr Urano has the Patent filed 1st for this as the original inventor.